The results obtained in this study demonstrate that etoposideloaded and FA-functionalized PHBV nanoparticles can be successfully used for targeted treatment of osteosarcoma.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Folic acid (FA)-functionalized poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles were prepared to enhance the delivery efficiency of the anticancer drug etoposide for the clinical treatment of osteosarcoma.
📊
Key Findings & Data:PHBV nanoparticles were synthesized by emulsification/solvent evaporation technique and obtained in the size range of 200 250 nm and zeta potential range of21 and 27 mV.
💡
Conclusion & Impact:The results obtained in this study demonstrate that etoposideloaded and FA-functionalized PHBV nanoparticles can be successfully used for targeted treatment of osteosarcoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Folic acid (FA)-functionalized poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles were prepared to enhance the delivery efficiency of the anticancer drug etoposide for the clinical treatment of osteosarcoma. PHBV nanoparticles were synthesized by emulsification/solvent evaporation technique and obtained in the size range of 200 250 nm and zeta potential range of21 and 27 mV. Encapsulation efficiency and in vitro drug release were studied. The cytotoxic, apoptotic, and necrotic effects of PHBV nanoparticles were also investigated using Saos-2 osteosarcoma cells. The results obtained in this study demonstrate that etoposideloaded and FA-functionalized PHBV nanoparticles can be successfully used for targeted treatment of osteosarcoma.
🔖
Cite This Article
DEMİRBİLEK, M., GÜVEN, E., ÇIRAK, T., ALP, E., TÜRK3, M. (2022). Targeted delivery of etoposide to osteosarcoma cells using poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles. Turkish Journal of Biology, Cilt: 41 - Sayı: 5, 719–733. https://ajindex.com/articles/600283
Baena-Aristizabal CM, Fessi H, Elaissari A, Mora-Huertas CE (2016). Biodegradable microparticles preparation by double emulsification-solvent extraction method: A systematic study. Colloid Surface A 492: 213-229.
Bajpai AK, Mishra A (2005). Preparation and characterization of tetracycline-loaded interpenetrating polymer networks of carboxymethyl cellulose and poly(acrylic acid): water sorption and drug release study. Polym Int 54: 1347-1356.
Decuzzi P, Ferrari M (2007). The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials 28: 2915-2922.
Dhanaraju MD, Sathyamoorthy N, Sundar VD, Suresh C (2010). Preparation of poly (epsilon-caprolactone) microspheres containing etoposide by solvent evaporation method. Asian Journal of Pharmaceutical Science 5: 114-122.
Gassner F, Owen AJ (1996). Some properties of poly(3- hydroxybutyrate)-poly(3-hydroxyvalerate) blends. Polym Int 39: 215-219.
Hande KR (1998). Etoposide: Four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34: 1514-1521.
Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA (2012). Nanotechnology-based approaches in anticancer research. Int J Nanomedicine 7: 4391-4408.
Kilicay E, Demirbilek M, Turk M, Guven E, Hazer B, Denkbas EB (2011). Preparation and characterization of poly(3- hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy. Eur J Pharm Sci 44: 310-320.
Low PS, Kularatne SA (2009). Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol 13: 256-262.
Lu XY, Zhang YL, Wang L (2010). Preparation and in vitro drug-release behavior of 5-fluorouracil-loaded poly(hydroxybutyrate-cohydroxyhexanoate) nanoparticles and microparticles. J Appl Polym Sci 116: 2944-2950.
Moongkarndi P, Kosem N, Kaslungka S, Luanratana O, Pongpan N, Neungton N (2004). Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J Ethnopharmacol 90: 161-166.
Park EK, Lee SB, Lee YM (2005). Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 26: 1053-1061.
Parveen S, Sahoo SK (2008). Polymeric nanoparticles for cancer therapy. J Drug Target 16: 108-123.
Patil S, Sandberg A, Heckert E, Self W, Seal S (2007). Protein adsorption and cellular upta